Lungyen Life Service Corporation (TPEX:5530)

Ligand Pharmaceuticals Revenue

Lungyen Life Service had revenue of 1.16B TWD in the quarter ending March 31, 2025, with 12.19% growth. This brings the company's revenue in the last twelve months to 4.29B, up 4.77% year-over-year. In the year 2024, Lungyen Life Service had annual revenue of 4.16B with 1.50% growth.

• Revenue (ttm): 4.29B
• Revenue Growth: +4.77%
• P/S Ratio: 5.63
• Revenue / Employee: 9.83M
• Employees: 436
• Market Cap: 24.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.16B	61.59M	1.50%
Dec 31, 2023	4.10B	133.10M	3.36%
Dec 31, 2022	3.96B	413.85M	11.66%
Dec 31, 2021	3.55B	-112.87M	-3.08%
Dec 31, 2020	3.66B	-895.84M	-19.65%